BIOAVAILABILITY OF DRUGS FROM FORMULATIONS AFTER ORAL-ADMINISTRATION

[1] ABBOTT AHA, 1943, QUART J PHARM, V16, P183

[2] POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) : 496 - &

[3] AGUIAR A J, 1969, Drug Information Bulletin, V3, P17

[4] ARIENS EJ, 1969, J MOND PHARM, V3, P263

[5] ARNOLD K, 1970, CAN J PHARM SCI, V5, P89

[6] BALDRIDGE J L, 1969, Bulletin of the Parenteral Drug Association, V23, P40

[7] BARR W H, 1969, Drug Information Bulletin, V3, P27

[8] BARR WH, 1972, CLIN PHARMACOL THER, V13, P97

[9] BARR WH, 1971, CLIN PHARMACOL THER, V12, P779

[10] BARR WH, 1968, AM J PHARM EDUC, V32, P958

[1] ABBOTT AHA, 1943, QUART J PHARM, V16, P183

[2] POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) : 496 - &

[3] AGUIAR A J, 1969, Drug Information Bulletin, V3, P17

[4] ARIENS EJ, 1969, J MOND PHARM, V3, P263

[5] ARNOLD K, 1970, CAN J PHARM SCI, V5, P89

[6] BALDRIDGE J L, 1969, Bulletin of the Parenteral Drug Association, V23, P40

[7] BARR W H, 1969, Drug Information Bulletin, V3, P27

[8] BARR WH, 1972, CLIN PHARMACOL THER, V13, P97

[9] BARR WH, 1971, CLIN PHARMACOL THER, V12, P779

[10] BARR WH, 1968, AM J PHARM EDUC, V32, P958